NCT03891251 Collecting Recorded Videos of Colonoscopy
| NCT ID | NCT03891251 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Magentiq Eye LTD |
| Condition | Colon Polyp |
| Study Type | OBSERVATIONAL |
| Enrollment | 700 participants |
| Start Date | 2018-12-19 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 700 participants in total. It began in 2018-12-19 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study shall mainly help to better evaluate the performance the APDS device and secondly it may help to assess the potential of the future alpha version of the device to be a useful and effective for the detection of colon Polyps.
Eligibility Criteria
Inclusion Criteria: Subjects must meet all the - criteria related to regular colonoscopy according to the standard of care at the Gastroenterology Department of the selected center, \_In addition the following - criteria have to be met to be eligible for the study: 1. Able to read, understand and provide written Informed Consent; 2. Females or males - older than 18 years old Exclusion Criteria: Any of the following colonoscopy related exclusion criteria will exclude the subject from the study: * Bleeding disorder or unacceptable risk of bleeding * Terminal illness or life threatening malignancy
Contact & Investigator
Harold Jacob, MD
PRINCIPAL INVESTIGATOR
Senior Gastroenterologist
Frequently Asked Questions
Who can join the NCT03891251 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Colon Polyp. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03891251 currently recruiting?
Yes, NCT03891251 is actively recruiting participants. Contact the research team at dror@magentiq.com for enrollment information.
Where is the NCT03891251 trial being conducted?
This trial is being conducted at Jerusalem, Israel.
Who is sponsoring the NCT03891251 clinical trial?
NCT03891251 is sponsored by Magentiq Eye LTD. The principal investigator is Harold Jacob, MD at Senior Gastroenterologist. The trial plans to enroll 700 participants.